Author Archives: Jose Marques Lopes PhD

Renflexis Now Reimbursed in British Columbia for Ankylosing Spondylitis, Other Indications

British Columbia is now reimbursing ankylosing spondylitis treatment Renflexis (infliximab-abda) under its public drug plan, according to Merck Canada. Besides adults with ankylosing spondylitis, the reimbursement — effective Aug. 21 — covers all other approved indications. Those include treatment of adult patients with rheumatoid arthritis, psoriatic arthritis…